公益財団法人田附興風会 医学研究所北野病院

inquiry
search close
MENU

Departments

Treatment details (Arrhythmia department)

Arrhythmia treatment in our department





In February 2025, atrial fibrillation ablation was changed to "pulsed field ablation," which can be performed in a short time without affecting surrounding organs.

Atrial fibrillation is a disease that causes heart failure, and if it persists, can lead to cerebral infarction and other conditions. It is feared that the number of patients will increase in the future due to factors such as aging. Until now, atrial fibrillation ablation was a catheter procedure that could be a fundamental treatment for atrial fibrillation, but because it involves cauterizing or freezing the thin atrial muscle, it had problems such as complications to surrounding organs and was time-consuming.

To solve these problems, our hospital has adopted "pulsed field ablation." An electric field is generated around the catheter, which treats only the targeted atrial muscle, leaving no effect on surrounding organs. Treatment takes only a few seconds per area, so the procedure is likely to be completed within an hour.




 

202410As of this month, the Arrhythmia Department has become able to perform all arrhythmia-related surgeries, including percutaneous transcatheter cardiac lead removal (※).

What is "Percutaneous Transcatheter Cardiac Lead Extraction"?

As Japan's population ages, cardiac devices such as pacemakers and implantable cardioverter defibrillators are becoming increasingly common.6million people (total25million people),65ages 18 and over100To people1However, if the leads connecting the cardiac devices to the heart chambers are damaged or become infected through skin infection or sepsis, it can be life-threatening.

To solve these problems, the procedure for removing leads is called "percutaneous transcatheter cardiac lead removal in addition to open-heart surgery." Currently, there are not many medical institutions in Osaka Prefecture that perform this procedure, so our department is expected to play an important role in the future.


In the hybrid operating room
Cardiac device lead removal surgery


Laser sheath etc.
Right ventricular lead removal was successful


After new right ventricular lead insertion

*On October 18, 2024, in a case of complete atrioventricular block, the right ventricular lead, which had become insufficient for pacing more than 10 years after implantation, was successfully removed and a new right ventricular lead was successfully re-implanted.

3: Tachyarrhythmia diagnosis and treatment

Arrhythmia is when the heart rate exceeds the normal rate, resulting in rapid heartbeat and causing palpitations, fainting, heart failure, etc.Portable electrocardiograph (Figure 1), long-term recording Holter electrocardiogram, implantable loop recorder (Figure 2)is used to identify the diagnosis.

Figure 1: Portable electrocardiograph
携帯心電計
Figure 2: Implantable loop recorder
植え込み型ループレコーダー

These tachyarrhythmias occur due to certain congenital or acquired abnormalities in the heart, so a three-dimensional arrhythmia mapping system (Cult 3 (Figure 3))orEnsite (Figure 4)) to identify the area and then freeze it with radiofrequency ablation, which uses heat from radiofrequency waves, or a balloon.Cryo-balloon ablation (Figure 5)We are currently working on the following.

Figure 3: Cult 3 System & Visitag
カルト3システム&Visitag
Figure 4: Ensight System
エンサイト・システム
Figure 5: Cryo-balloon ablation
クライオ・バルーン・アブレーション

Our department started in 2008 and has been treating not only conventional tachyarrhythmia but also refractory arrhythmias such as persistent atrial fibrillation and ventricular tachycardia associated with organic heart disease. In 2017, we treated 242 cases.(Figure 6)It is one of the leading facilities for catheter ablation in Osaka Prefecture.Chemical ablation of the Marshall veinWe are constantly working on new treatments such as:

Figure 6: Catheter ablation cases at our hospital
当院におけるカテーテル・アブレーション症例実績

For tachyarrhythmias that remain life-threatening even after catheter ablation,Detachable cardiac defibrillator (Figure 7)orimplantable cardioverter-defibrillatorIn addition, after implantation,Remote Monitoring SystemWe manage this system so that we can respond quickly.

Figure 7: Detachable cardiac defibrillator (Asahi Kasei)
着脱型心臓除細動器(旭化成)

Information